Incremental Prognostic Value of Echocardiography Measures of Right Ventricular Systolic Function in Patients With Chronic Heart Failure

Background Tricuspid annular plane systolic excursion (TAPSE), Doppler tissue imaging–derived tricuspid lateral annular systolic wave velocity (S′), and right ventricular fractional area change (RV‐FAC) are the most widely used echocardiographic measures of right ventricular systolic function. This...

Full description

Saved in:
Bibliographic Details
Main Authors: Francesco Gentile, Michela Chianca, Lorenzo Bazan, Paolo Sciarrone, Vlad Chubuchny, Claudia Taddei, Elisa Poggianti, Claudio Passino, Michele Emdin, Alberto Giannoni
Format: Article
Language:English
Published: Wiley 2025-03-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.124.038616
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850155087766224896
author Francesco Gentile
Michela Chianca
Lorenzo Bazan
Paolo Sciarrone
Vlad Chubuchny
Claudia Taddei
Elisa Poggianti
Claudio Passino
Michele Emdin
Alberto Giannoni
author_facet Francesco Gentile
Michela Chianca
Lorenzo Bazan
Paolo Sciarrone
Vlad Chubuchny
Claudia Taddei
Elisa Poggianti
Claudio Passino
Michele Emdin
Alberto Giannoni
author_sort Francesco Gentile
collection DOAJ
description Background Tricuspid annular plane systolic excursion (TAPSE), Doppler tissue imaging–derived tricuspid lateral annular systolic wave velocity (S′), and right ventricular fractional area change (RV‐FAC) are the most widely used echocardiographic measures of right ventricular systolic function. This study aimed to compare the prognostic value of TAPSE, S′, and RV‐FAC in a large cohort of patients with chronic heart failure. Methods Consecutive outpatients with heart failure and left ventricular ejection fraction <50% on guideline‐recommended therapies undergoing echocardiography were followed up for the end point of cardiac and all‐cause death. Results Among 1590 patients (71±12 years, 77% men, left ventricular ejection fraction 34%±9%), 202 (13%) died from cardiac causes during a median follow‐up of 28 (interquartile range, 14–40) months. According to the recommended cut points for TAPSE (<17 mm), S′ (<9.5 cm/s), or RV‐FAC (<35%), right ventricular systolic dysfunction was found in 37%, 40%, and 35% of patients, respectively, with 21%, 31%, and 33% of discordant cases comparing TAPSE versus S′, TAPSE versus RV‐FAC, and S′ versus RV‐FAC. Both TAPSE <17 mm and RV‐FAC <35% were more accurate than S′ <9.5 cm/s in predicting the risk of cardiac death (P<0.001), and their combination showed incremental prognostic power (P<0.001). Adding S′ to the combination of TAPSE and RV‐FAC did not provide further incremental value (P=0.145). Similar findings were obtained when all‐cause death was considered as the end point. Conclusions In patients with chronic heart failure and left ventricular ejection fraction <50%, TAPSE, and RV‐FAC are more accurate than S′ in predicting the risk of cardiac and all‐cause death. Considering both RV‐FAC and TAPSE provides incremental prognostic value.
format Article
id doaj-art-089faa6b2fd04e8fb42a481ca2e603b0
institution OA Journals
issn 2047-9980
language English
publishDate 2025-03-01
publisher Wiley
record_format Article
series Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
spelling doaj-art-089faa6b2fd04e8fb42a481ca2e603b02025-08-20T02:25:02ZengWileyJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease2047-99802025-03-0114510.1161/JAHA.124.038616Incremental Prognostic Value of Echocardiography Measures of Right Ventricular Systolic Function in Patients With Chronic Heart FailureFrancesco Gentile0Michela Chianca1Lorenzo Bazan2Paolo Sciarrone3Vlad Chubuchny4Claudia Taddei5Elisa Poggianti6Claudio Passino7Michele Emdin8Alberto Giannoni9Health Science Interdisciplinary Center Scuola Superiore Sant’Anna Pisa ItalyHealth Science Interdisciplinary Center Scuola Superiore Sant’Anna Pisa ItalyHealth Science Interdisciplinary Center Scuola Superiore Sant’Anna Pisa ItalyHealth Science Interdisciplinary Center Scuola Superiore Sant’Anna Pisa ItalyFondazione Toscana Gabriele Monasterio Pisa ItalyFondazione Toscana Gabriele Monasterio Pisa ItalyFondazione Toscana Gabriele Monasterio Pisa ItalyHealth Science Interdisciplinary Center Scuola Superiore Sant’Anna Pisa ItalyHealth Science Interdisciplinary Center Scuola Superiore Sant’Anna Pisa ItalyHealth Science Interdisciplinary Center Scuola Superiore Sant’Anna Pisa ItalyBackground Tricuspid annular plane systolic excursion (TAPSE), Doppler tissue imaging–derived tricuspid lateral annular systolic wave velocity (S′), and right ventricular fractional area change (RV‐FAC) are the most widely used echocardiographic measures of right ventricular systolic function. This study aimed to compare the prognostic value of TAPSE, S′, and RV‐FAC in a large cohort of patients with chronic heart failure. Methods Consecutive outpatients with heart failure and left ventricular ejection fraction <50% on guideline‐recommended therapies undergoing echocardiography were followed up for the end point of cardiac and all‐cause death. Results Among 1590 patients (71±12 years, 77% men, left ventricular ejection fraction 34%±9%), 202 (13%) died from cardiac causes during a median follow‐up of 28 (interquartile range, 14–40) months. According to the recommended cut points for TAPSE (<17 mm), S′ (<9.5 cm/s), or RV‐FAC (<35%), right ventricular systolic dysfunction was found in 37%, 40%, and 35% of patients, respectively, with 21%, 31%, and 33% of discordant cases comparing TAPSE versus S′, TAPSE versus RV‐FAC, and S′ versus RV‐FAC. Both TAPSE <17 mm and RV‐FAC <35% were more accurate than S′ <9.5 cm/s in predicting the risk of cardiac death (P<0.001), and their combination showed incremental prognostic power (P<0.001). Adding S′ to the combination of TAPSE and RV‐FAC did not provide further incremental value (P=0.145). Similar findings were obtained when all‐cause death was considered as the end point. Conclusions In patients with chronic heart failure and left ventricular ejection fraction <50%, TAPSE, and RV‐FAC are more accurate than S′ in predicting the risk of cardiac and all‐cause death. Considering both RV‐FAC and TAPSE provides incremental prognostic value.https://www.ahajournals.org/doi/10.1161/JAHA.124.038616echocardiographyheart failureoutcomeright ventricleRV‐FACS′
spellingShingle Francesco Gentile
Michela Chianca
Lorenzo Bazan
Paolo Sciarrone
Vlad Chubuchny
Claudia Taddei
Elisa Poggianti
Claudio Passino
Michele Emdin
Alberto Giannoni
Incremental Prognostic Value of Echocardiography Measures of Right Ventricular Systolic Function in Patients With Chronic Heart Failure
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
echocardiography
heart failure
outcome
right ventricle
RV‐FAC
S′
title Incremental Prognostic Value of Echocardiography Measures of Right Ventricular Systolic Function in Patients With Chronic Heart Failure
title_full Incremental Prognostic Value of Echocardiography Measures of Right Ventricular Systolic Function in Patients With Chronic Heart Failure
title_fullStr Incremental Prognostic Value of Echocardiography Measures of Right Ventricular Systolic Function in Patients With Chronic Heart Failure
title_full_unstemmed Incremental Prognostic Value of Echocardiography Measures of Right Ventricular Systolic Function in Patients With Chronic Heart Failure
title_short Incremental Prognostic Value of Echocardiography Measures of Right Ventricular Systolic Function in Patients With Chronic Heart Failure
title_sort incremental prognostic value of echocardiography measures of right ventricular systolic function in patients with chronic heart failure
topic echocardiography
heart failure
outcome
right ventricle
RV‐FAC
S′
url https://www.ahajournals.org/doi/10.1161/JAHA.124.038616
work_keys_str_mv AT francescogentile incrementalprognosticvalueofechocardiographymeasuresofrightventricularsystolicfunctioninpatientswithchronicheartfailure
AT michelachianca incrementalprognosticvalueofechocardiographymeasuresofrightventricularsystolicfunctioninpatientswithchronicheartfailure
AT lorenzobazan incrementalprognosticvalueofechocardiographymeasuresofrightventricularsystolicfunctioninpatientswithchronicheartfailure
AT paolosciarrone incrementalprognosticvalueofechocardiographymeasuresofrightventricularsystolicfunctioninpatientswithchronicheartfailure
AT vladchubuchny incrementalprognosticvalueofechocardiographymeasuresofrightventricularsystolicfunctioninpatientswithchronicheartfailure
AT claudiataddei incrementalprognosticvalueofechocardiographymeasuresofrightventricularsystolicfunctioninpatientswithchronicheartfailure
AT elisapoggianti incrementalprognosticvalueofechocardiographymeasuresofrightventricularsystolicfunctioninpatientswithchronicheartfailure
AT claudiopassino incrementalprognosticvalueofechocardiographymeasuresofrightventricularsystolicfunctioninpatientswithchronicheartfailure
AT micheleemdin incrementalprognosticvalueofechocardiographymeasuresofrightventricularsystolicfunctioninpatientswithchronicheartfailure
AT albertogiannoni incrementalprognosticvalueofechocardiographymeasuresofrightventricularsystolicfunctioninpatientswithchronicheartfailure